Vaxart, Inc. (VXRT)
Develops pill-form vaccines that work through the digestive system instead of injections
$0.48+0.07%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago+33.2%
The outlook
VXRT is trading near the lower end of its 52-week range and below both its 50- and 200-day moving averages, reflecting a bearish near-term trend. Analyst coverage shows an average price target roughly 6x the current price, though the stock's overall momentum score leans bearish. The valuation appears compressed with a trailing P/E of 3.0.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range32% of the way from its 52-week low to high
Price targetAvg target +595% vs current price
Analyst price target
~12-month · 3 analysts$3.33average target+595.2% vs now
Now $0.48
Low $2.00High $4.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$116.1M
52-wk high
$0.84
52-wk low
$0.31
50-day avg
$0.58
200-day avg
$0.55
Trailing P/E
3.0